Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03440619 · ClinicalTrials.gov registry record · NA
INVSENSOR00013 Respiratory Rate Clinical Performance Study
A NA study, sponsored by Masimo Corporation.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT03440619 is a NA study that has completed, run by Masimo Corporation. The registered enrollment target is 28 participants.
The verdict
NCT03440619, a NA study, has completed, sponsored by Masimo Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
The objective of this prospective study is to compare the noninvasive respiration from pleth (RRp) performance of the Masimo INVSENSOR00013 device against the respiratory rate measured by capnography (RRref), Masimo's RAM technology and the manual annotation.
Interventions
- DEVICE INVSENSOR00013
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2018-02-06 |
| Est. Completion | 2018-02-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03440619
The ClinicalTrials.gov registry entry for NCT03440619 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masimo Corporation, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which INVSENSOR00013 is the first listed.
NCT03440619 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03440619 about?
NCT03440619 is a clinical study titled "INVSENSOR00013 Respiratory Rate Clinical Performance Study". The objective of this prospective study is to compare the noninvasive respiration from pleth (RRp) performance of the Masimo INVSENSOR00013 device against the respiratory rate measured by capnography (RRref), Masimo's RAM technology and the manual annotation.
What is the current status of trial NCT03440619?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2018-02-06. Estimated completion is 2018-02-14.
What interventions are being tested in trial NCT03440619?
The interventions under investigation include: INVSENSOR00013 (DEVICE).
Who is sponsoring clinical trial NCT03440619?
This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.